ArticleScientific reports2026
Factors influencing malignant tumor development in cats from a multicenter retrospective study.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Animal cancer registries (ACRs) are vital tools in veterinary oncology, offering insights into tumor epidemiology and supporting comparative research. Despite cancer being a major cause of feline mortality, data on feline tumor epidemiology remain limited. This study aimed to investigate temporal trends in histologically diagnosed feline tumors and assess how breed, sex, neuter status, age, and geographic origin affect malignancy and tumor distribution. A modified Vet-ICD-O-canine-1 coding system was applied to 5,289 tumors from two pathology-based ACRs in central Italy (2008-2023). Data were analyzed for time trends by the Cochrane-Armitage test, and logistic regression was used to assess the impact of the variables on tumor behavior ("malignant" vs. "benign") and the development of major cancer types. Of all tumors, 4,264 (80.6%) were malignant. Fibrosarcomas (n = 926; 17.5%), adenocarcinomas (n = 814; 15.4%), squamous cell carcinomas (SCCs; n = 738; 14.0%), and lymphomas (n = 507; 9.6%) were the most common types of cancer. Malignancy risk increased by 8% per year of age (OR = 1.08; 95%CI 1.06-1.10). Females (OR = 1.39; 95%CI 1.19-1.62) and non-purebred cats (OR = 1.89; 95%CI 1.47-2.38) had higher odds of malignancy. Neutered status was associated with reduced adenocarcinoma risk (OR = 0.79; 95% CI 0.66-0.94). Temporal trends included rising SCCs (p = 0.001) and declining fibrosarcomas (p < 0.001). These findings support previous findings and identify previously unknown risk factors, underscoring the value of multicenter ACR-based surveillance.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.